(a) Define “pharmaceutical product” under the Pharmacy and Poisons Ordinance.

(b) Describe the registration requirements, exemptions and factors relevant to determination of application for registration of pharmaceutical product as stipulated under the Pharmacy and Poisons Regulations.

(c) Describe the labeling requirements with respect to pharmaceutical products containing alpelisib as active ingredient. (20 marks)